{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:02:00Z","timestamp":1784595720509,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 DK124399"],"award-info":[{"award-number":["R01 DK124399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02147-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:23:30Z","timestamp":1779290610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOL1 risk genotypes influence DNA methylation across multiple genomic elements in APOL1-APOL4-\u00a0MYH9\u00a0region in African Americans"],"prefix":"10.1186","volume":"18","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Bozack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Waterh\u00f6lter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulema","family":"Rodriguez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly V.","family":"Ruggles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"3","key":"2147_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","volume":"128","author":"S Tzur","year":"2010","unstructured":"Tzur S, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010;128(3):345\u201350.","journal-title":"Hum Genet"},{"issue":"5","key":"2147_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/MNH.0000000000000816","volume":"31","author":"DJ Friedman","year":"2022","unstructured":"Friedman DJ, Ma L, Freedman BI. Treatment potential in APOL1-associated nephropathy. Curr Opin Nephrol Hypertens. 2022;31(5):442\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3 Suppl 1","key":"2147_CR3","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","volume":"69","author":"R Saran","year":"2017","unstructured":"Saran R, et al. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2147_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","volume":"22","author":"JB Kopp","year":"2011","unstructured":"Kopp JB, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011;22(11):2129\u201337.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"2147_CR5","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"A Parsa","year":"2013","unstructured":"Parsa A, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183\u201396.","journal-title":"N Engl J Med"},{"issue":"6","key":"2147_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.semnephrol.2017.07.003","volume":"37","author":"DJ Friedman","year":"2017","unstructured":"Friedman DJ. A brief history of APOL1: a gene evolving. Semin Nephrol. 2017;37(6):508\u201313.","journal-title":"Semin Nephrol"},{"issue":"R1","key":"2147_CR7","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1093\/hmg\/ddab024","volume":"30","author":"AA Yusuf","year":"2021","unstructured":"Yusuf AA, et al. Kidney disease and APOL1. Hum Mol Genet. 2021;30(R1):R129\u201337.","journal-title":"Hum Mol Genet"},{"issue":"26","key":"2147_CR8","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1056\/NEJMc1800748","volume":"379","author":"GN Nadkarni","year":"2018","unstructured":"Nadkarni GN, et al. Worldwide frequencies of APOL1 renal risk variants. N Engl J Med. 2018;379(26):2571\u20132.","journal-title":"N Engl J Med"},{"issue":"2","key":"2147_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ki.2014.270","volume":"87","author":"B Nichols","year":"2015","unstructured":"Nichols B, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2015;87(2):332\u201342.","journal-title":"Kidney Int"},{"issue":"4","key":"2147_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.4287","volume":"23","author":"P Beckerman","year":"2017","unstructured":"Beckerman P, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017;23(4):429\u201338.","journal-title":"Nat Med"},{"issue":"5","key":"2147_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.085647.108","volume":"19","author":"EE Smith","year":"2009","unstructured":"Smith EE, Malik HS. The Apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res. 2009;19(5):850\u20138.","journal-title":"Genome Res"},{"issue":"12","key":"2147_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051546","volume":"7","author":"DB Johnstone","year":"2012","unstructured":"Johnstone DB, et al. APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS ONE. 2012;7(12):e51546.","journal-title":"PLoS ONE"},{"issue":"26","key":"2147_CR13","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1056\/NEJMoa063265","volume":"355","author":"B Vanhollebeke","year":"2006","unstructured":"Vanhollebeke B, et al. Human Trypanosoma evansi infection linked to a lack of Apolipoprotein L-I. N Engl J Med. 2006;355(26):2752\u20136.","journal-title":"N Engl J Med"},{"key":"2147_CR14","doi-asserted-by":"crossref","unstructured":"Aghajan, M., et al., Antisense oligonucleotide treatment ameliorates IFN-gamma-induced proteinuria in APOL1-transgenic mice. JCI Insight, 2019. 4(12).","DOI":"10.1172\/jci.insight.126124"},{"issue":"7","key":"2147_CR15","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.ymthe.2022.04.007","volume":"30","author":"YW Yang","year":"2022","unstructured":"Yang YW, et al. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice. Mol Ther. 2022;30(7):2491\u2013504.","journal-title":"Mol Ther"},{"issue":"11","key":"2147_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa2202396","volume":"388","author":"O Egbuna","year":"2023","unstructured":"Egbuna O, et al. Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N Engl J Med. 2023;388(11):969\u201379.","journal-title":"N Engl J Med"},{"issue":"11","key":"2147_CR17","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.ekir.2023.08.028","volume":"8","author":"G Vasquez-Rios","year":"2023","unstructured":"Vasquez-Rios G, De Cos M, Campbell KN. Novel therapies in APOL1-mediated kidney disease: from molecular pathways to therapeutic options. Kidney Int Rep. 2023;8(11):2226\u201334.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"2147_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","volume":"34","author":"AM Hung","year":"2023","unstructured":"Hung AM, et al. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease. J Am Soc Nephrol. 2023;34(11):1889\u201399.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2147_CR19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.ekir.2024.06.033","volume":"9","author":"OA Olabisi","year":"2024","unstructured":"Olabisi OA, et al. Design and rationale of the phase 2 Baricitinib study in Apolipoprotein L1-mediated kidney disease (JUSTICE). Kidney Int Rep. 2024;9(9):2677\u201384.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2147_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12864-024-10226-0","volume":"25","author":"CE Breeze","year":"2024","unstructured":"Breeze CE, et al. African ancestry-derived APOL1 risk genotypes show proximal epigenetic associations. BMC Genomics. 2024;25(1):452.","journal-title":"BMC Genomics"},{"issue":"8","key":"2147_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1681\/ASN.0000000688","volume":"36","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. Alterations in DNA methylation, proteomic, and metabolomic profiles in African ancestry populations with APOL1 risk alleles. J Am Soc Nephrol. 2025;36(8):1490\u2013504.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"2147_CR22","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","volume":"77","author":"JD Wright","year":"2021","unstructured":"Wright JD, et al. The ARIC (Atherosclerosis Risk In Communities) Study: JACC focus seminar 3\/8. J Am Coll Cardiol. 2021;77(23):2939\u201359.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2147_CR23","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1681\/ASN.2013010113","volume":"24","author":"MC Foster","year":"2013","unstructured":"Foster MC, et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol. 2013;24(9):1484\u201391.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2147_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jgs.16797","volume":"69","author":"TK Chen","year":"2021","unstructured":"Chen TK, et al. Race, APOL1 risk variants, and clinical outcomes among older adults: The ARIC study. J Am Geriatr Soc. 2021;69(1):155\u201363.","journal-title":"J Am Geriatr Soc"},{"issue":"5993","key":"2147_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841\u20135.","journal-title":"Science"},{"issue":"5","key":"2147_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","volume":"21","author":"S Limou","year":"2014","unstructured":"Limou S, et al. APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014;21(5):426\u201333.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"2147_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13059-015-0600-x","volume":"16","author":"B Lehne","year":"2015","unstructured":"Lehne B, et al. A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies. Genome Biol. 2015;16(1):37.","journal-title":"Genome Biol"},{"key":"2147_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman EA, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.","journal-title":"BMC Bioinformatics"},{"issue":"19","key":"2147_CR29","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, et al. New Creatinine- and Cystatin C-based equations to estimate GFR without Race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"key":"2147_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bax028","author":"S Fishilevich","year":"2017","unstructured":"Fishilevich S, et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017. https:\/\/doi.org\/10.1093\/database\/bax028.","journal-title":"Database (Oxford)"},{"key":"2147_CR31","unstructured":"Poole, W., EmpiricalBrownsMethod: Uses Brown's method to combine p-values from dependent tests. https:\/\/doi.org\/10.18129\/B9.bioc.EmpiricalBrownsMethod, R package version 1.38.0, https:\/\/bioconductor.org\/packages\/EmpiricalBrownsMethod. 2015."},{"issue":"5","key":"2147_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/ndt\/gfae237","volume":"40","author":"RKY Hung","year":"2025","unstructured":"Hung RKY, et al. Epigenetic associations with kidney disease in individuals of African ancestry with APOL1 high-risk genotypes and HIV. Nephrol Dial Transplant. 2025;40(5):997\u20131006.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2147_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2010.251","volume":"78","author":"G Genovese","year":"2010","unstructured":"Genovese G, et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 2010;78(7):698\u2013704.","journal-title":"Kidney Int"},{"issue":"11","key":"2147_CR34","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1681\/ASN.2020070954","volume":"31","author":"E Pays","year":"2020","unstructured":"Pays E. The mechanism of kidney disease due to APOL1 risk variants. J Am Soc Nephrol. 2020;31(11):2502\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2147_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113528","volume":"42","author":"L Lecordier","year":"2023","unstructured":"Lecordier L, et al. Apolipoproteins L1 and L3 control mitochondrial membrane dynamics. Cell Rep. 2023;42(12):113528.","journal-title":"Cell Rep"},{"issue":"1","key":"2147_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.tig.2021.07.008","volume":"38","author":"OQH Zinani","year":"2022","unstructured":"Zinani OQH, Keseroglu K, Ozbudak EM. Regulatory mechanisms ensuring coordinated expression of functionally related genes. Trends Genet. 2022;38(1):73\u201381.","journal-title":"Trends Genet"},{"key":"2147_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-94-007-4525-4_13","volume":"61","author":"JL Miller","year":"2013","unstructured":"Miller JL, Grant PA. The role of DNA methylation and histone modifications in transcriptional regulation in humans. Subcell Biochem. 2013;61:289\u2013317.","journal-title":"Subcell Biochem"},{"issue":"3","key":"2147_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/MNH.0000000000001068","volume":"34","author":"MR Pollak","year":"2025","unstructured":"Pollak MR, Friedman DJ. APOL1-associated kidney disease: modulators of the genotype-phenotype relationship. Curr Opin Nephrol Hypertens. 2025;34(3):191\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1\u20133","key":"2147_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2008.05.028","volume":"104","author":"S Takahashi","year":"2008","unstructured":"Takahashi S, et al. Association of SNPs and haplotypes in APOL1, 2 and 4 with schizophrenia. Schizophr Res. 2008;104(1\u20133):153\u201364.","journal-title":"Schizophr Res"},{"key":"2147_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195765","author":"H Zhu","year":"2022","unstructured":"Zhu H, et al. APOL4, a novel immune-related prognostic biomarker for glioma. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11195765.","journal-title":"J Clin Med"},{"key":"2147_CR41","doi-asserted-by":"publisher","first-page":"8348780","DOI":"10.1155\/2022\/8348780","volume":"2022","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang F. Identification of ten-gene related to lipid metabolism for predicting overall survival of breast invasive carcinoma. Contrast Media Mol Imaging. 2022;2022:8348780.","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"2147_CR42","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/s12885-025-14316-4","volume":"25","author":"M Zhang","year":"2025","unstructured":"Zhang M, Yang T, Qian Y. APOL4-mediated intracellular cholesterol trafficking is essential for glioblastoma cell growth. BMC Cancer. 2025;25(1):906.","journal-title":"BMC Cancer"},{"issue":"2","key":"2147_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41386-019-0500-y","volume":"45","author":"A Luo","year":"2020","unstructured":"Luo A, et al. Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2. Neuropsychopharmacology. 2020;45(2):327\u201336.","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"2147_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100665","volume":"4","author":"E Pays","year":"2025","unstructured":"Pays E. Apolipoprotein L2\u2019s role in liver fibrosis. Gastro Hep Adv. 2025;4(7):100665.","journal-title":"Gastro Hep Adv"},{"issue":"1","key":"2147_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41589-024-01704-3","volume":"21","author":"L Gan","year":"2025","unstructured":"Gan L, et al. A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. Nat Chem Biol. 2025;21(1):80\u201390.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"2147_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg2957","volume":"12","author":"CT Ong","year":"2011","unstructured":"Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011;12(4):283\u201393.","journal-title":"Nat Rev Genet"},{"key":"2147_CR47","doi-asserted-by":"crossref","unstructured":"Zhang, D.Y., et al., Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles. JCI Insight, 2024. 9(19).","DOI":"10.1172\/jci.insight.181238"},{"issue":"2","key":"2147_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/ndt\/gfw451","volume":"33","author":"KL Skorecki","year":"2018","unstructured":"Skorecki KL, et al. A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrol Dial Transplant. 2018;33(2):323\u201330.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2147_CR49","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ckj\/sfy117","volume":"12","author":"N Tabibzadeh","year":"2019","unstructured":"Tabibzadeh N, et al. MYH9-related disorders display heterogeneous kidney involvement and outcome. Clin Kidney J. 2019;12(4):494\u2013502.","journal-title":"Clin Kidney J"},{"key":"2147_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176806","volume":"979","author":"F Wang","year":"2024","unstructured":"Wang F, et al. SFN promotes renal fibrosis via binding with MYH9 in chronic kidney disease. Eur J Pharmacol. 2024;979:176806.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2147_CR51","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/15592294.2021.1924970","volume":"17","author":"D Beck","year":"2022","unstructured":"Beck D, Ben Maamar M, Skinner MK. Genome-wide CpG density and DNA methylation analysis method (MeDIP, RRBS, and WGBS) comparisons. Epigenetics. 2022;17(5):518\u201330.","journal-title":"Epigenetics"},{"issue":"19","key":"2147_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab637","volume":"49","author":"TJ Peters","year":"2021","unstructured":"Peters TJ, et al. Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate. Nucleic Acids Res. 2021;49(19):e109.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2147_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/epi-2020-0344","volume":"13","author":"S Lent","year":"2021","unstructured":"Lent S, et al. Detecting differentially methylated regions with multiple distinct associations. Epigenomics. 2021;13(6):451\u201364.","journal-title":"Epigenomics"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02147-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:10:00Z","timestamp":1784592600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02147-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02147-4","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent for collection, analysis, and publication of their study data and results of laboratory tests derived from their biospecimens. The manuscript was reviewed by the ARIC Publications Committee which provided its approval for submission of this work for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants enrolled in the ARIC completed informed consent at the time of enrollment into the cohort and subsequently provided informed consent. IRBs of all participating institutions approved the study. All experimental methods comply with the Helsinki Declaration.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"147"}}